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Introduction: Cytochrome P 450 enzymes (CYPs) were presumed 
to play a role in the oxidation of intermediate metabolites of busul-
fan (Bu). In vitro elucidation of involvement of CYPs in the oxi-
dation of Bu metabolites is cumbersome due to the volatile nature 
of tetrahydrothiophene and nonavailability of sensitive quantita-
tion methods. This study is aimed at exploring the association of 
CYP2C9, CYP2C19, CYP2B6, FMO genotypes, and sulfolane (Su) 
levels in children undergoing hematopoietic stem cell transplantation 
(HSCT).The relation of genotypes with the outcomes of HSCT was 
also explored.
Patients (or Materials) and Methods: Sixty-six children receiving IV 
Bu-based myeloablative conditioning regimen were genotyped for 
common functional variant alleles in CYP2C9 (*2 and *3), CYP2C19 
(*2 and *17), FMO3 (rs2266780, rs2266782 and rs1736557) and 
CYP2B6 (*5 and *9). Plasma levels of Bu and its metabolite Su were 
measured after dose 9 from a subset of 44 patients for whom plasma 
samples after dose 9 were available. The ratio of Bu to Su was taken 
as a metabolic ratio (MR) to compare among genotype groups. The 
MRs (Bu/Su), Bu and Su levels between different genotype groups 
were compared using nonparametric tests. The distribution of age, 
and gender between the groups was compared using t test and chi-
square test, respectively. Cumulative incidence of overall survival and 
event-free survival were estimated using Kaplan-Meier curves and 
log-rank test was used to compare the difference between genotype 
groups or groups divided on the basis of MR, in a univariate analysis. 
Multivariate analysis was performed using cox-regression analysis.
Results: Higher metabolic ratios (MRs, Bu/Su) were observed in 
CYP2C9*2 and *3 allele carriers (mean [SD], 7.8 [3.6] Vs 4.4 [2.2]; 
P = 0.003). Lower event-free survival was seen in patients with MR 
above the median 5 (40% vs 79%; P = 0.009) and carrying reduced 
function alleles of CYP2B6 (40% vs 84%; P = 0.005).
Conclusion: This study suggests the role of the CYP2C9 in the oxi-
dation reactions of THT and CYP genotypes along with Bu MRs 
to be important at predicting outcomes of Bu based myeloablative 
conditioning before HSCT.
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Introduction: Nevirapine (NVP) is a non-nucleoside reverse tran-
scriptase inhibitor (NNRTI) widely used in antiretroviral therapy 
(ART) in sub-Saharan Africa. Approximately 5% of patients 
receiving NVP-containing regimens develop hypersensitivity reac-
tions (HSRs). These can manifest as more severe reactions includ-
ing Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis 
(TEN), and hepatotoxicity. Various human leukocyte antigen (HLA) 
alleles have been associated to NVP-induced HSRs in populations 
of differing ethnicity. Carriage of HLA-C*04:01 is associated with 
an increased risk of SJS in our Malawian cohort. We investigated 
whether expression levels of miR-148a, a microRNA known to regu-
late HLA-C expression, differ in serum samples from hypersensitive 
and tolerant patients. The aim of the study was to identify the role 
of posttranscriptional regulation of HLA-C expression in HLA-
associated NVP-induced HSRs.
Patients (or Materials) and Methods: A total of 1117 HIV-positive 
patients in Malawi treated with a NVP-containing regimen were 
recruited prospectively. Of these, 57 patients developed NVP-induced 
HSRs. MicroRNA expression was analyzed using TaqMan probe–
based qPCR in available serum samples of 41 tolerant and 33 hyper-
sensitive patients. Expression levels were compared in hypersensitive 
patients at baseline (n = 19) and during the acute phase of the reac-
tion (n = 26). Tolerant baseline (n = 25) and week 6 (n = 27) samples 
were used as controls. Data were analyzed using nonparametric tests.
Results: There was no significant difference in the baseline expres-
sion of miR-148a between tolerant and hypersensitive patients. In 
our cohort, miR-148a expression showed a 4.6-fold increase in acute 
hypersensitive samples, when compared with baseline hypersensitive 
(P = 0.008). This was not observed in samples from tolerant patients.
Conclusion: Our study has identified an increase in miR-148a 
expression levels in serum samples from Malawian nevirapine 
hypersensitive patients during the acute phase. The reason(s) for the 
change in expression during the acute phase are unclear but may be 
related to the ongoing inflammation associated with a HSR. Further 
investigation is required to elucidate the mechanism of the rise in 
microRNA levels and any implications this may have on the severity 
and duration of the HSR.
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Introduction: Resistance to anticonvulsants affects one third of all 
epilepsy patients. Limited bioavailability of the drug at the target site 
caused by increased expression of efflux transporters on the blood 
brain barrier or alterations of target genes as well as seizure-induced 
neural reorganization are potential mechanisms for therapy resist-
ance. There is increasing evidence that expression of microRNAs 
(miRNAs) is deregulated in neuronal disorders. We hypothesize that 
an altered miRNA regulation of target genes is involved in drug 
resistance in epilepsy.
Patients (or Materials) and Methods: Hippocampal focal and corti-
cal nonfocal brain tissue samples from 13 patients diagnosed with 
MTS (mesial temporal sclerosis) who underwent neurosurgery have 
been screened for miRNA expression using TaqMan® low-density 
arrays. To compare miRNA expression between brain regions, a 
Mann-Whitney U test was performed using R (Bioconductor). In 
silico approaches for both a hypothesis-based (efflux-transporter 
and target gene) as well as a hypothesis-free approach were used 
